Dispatch from CTAD 2024
Would you want to know if you were on the road to Alzheimer’s 20 years before you have any memory loss? My feeling is…
Would you want to know if you were on the road to Alzheimer’s 20 years before you have any memory loss? My feeling is…
For years, a commonly prescribed treatment for managing the symptoms of Alzheimer’s disease has been a type of drug called a cholinesterase inhibitor (ChEI)….
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. When you’re concerned about…
On October 23nd, the UK’s drug regulation agency — UK Medicines and Healthcare products Regulatory Agency — approved Eli Lilly’s anti-amyloid drug Kisunla for…
In just a single year of studying a rare genetic mutation in a single family in the Arctic reaches of remote northern Sweden, a…
Did you know 1/5 people who see a doctor with cognitive concerns are misdiagnosed? Dementia, in all its many forms — including Alzheimer’s, Parkinson’s,…
As Halloween approaches, families look forward to celebrations, costumes, and candy. However, for individuals living with dementia, the holiday’s sudden noises, flashing lights, and…
There was disagreement on social media recently after a story was published about an aged care provider creating “fake-away” burgers that mimicked those from…
Over 80 percent of people living with Alzheimer’s disease are unable to recognize their own cognitive decline, according to Cleveland Clinic. Anosognosia is the…
When a family member is diagnosed with dementia, the people that step into the caregiving role are often those closest to them. Caregivers must…
Positive Approach to Care founder and dementia care expert Teepa Snow returns to our Live Talks series for another session of “Ask Teepa Anything,”…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. What would you do…
Parasites take an enormous toll on human and veterinary health. But researchers may have found a way for patients with brain disorders and a…
The new monoclonal anti-amyloid Alzheimer’s drugs are a constant source of controversy among doctors, insurers, and regulators worldwide. One of this buzzy new drug class,…
This article is part of the Diversity & Dementia series, produced by Being Patient with support provided by Eisai. Latino and Hispanic populations have…